Martin Rosendale

Martin Rosendale

Martin Rosendale

CEO, Selnova, LLC

Martin is the Founder and CEO of Selnova, LLC an advisory firm founded to help biotechnology entrepreneurs accelerate the development of great ideas. He utilizes his leadership experience, knowledge, and access to a large network of technical and corporate professionals to support companies through critical transitions.

With over 30 years of experience developing and commercializing therapeutic products and devices, Martin has led several successful businesses in various market sectors including medical biologics, drugs, medical devices, and plastics. He has launched, branded, acquired or commercialized more than 10 products and companies. He has raised equity-based capital for public and private companies and non-dilutive capital through strategic partnerships. Martin has also provided technical support or corporate advice to companies in the biotechnology and food preparation market sectors.

Martin has presented in public forums to numerous audiences on a variety of topics including, corporate investment, medical products, healthcare reimbursement, and infectious disease. He has been a Board member for Nuo Therapeutics, the Transplant Recipients International Organization, the American Red Cross, San Jose Region and the Maryland Cyber Security Council. He also served on the Health Advisory Committee for past California State Senator Diane Watson.

For more information see www.Selnova.com.